BeOne Medicines

BeOne Medicines is a global oncology company focused on transforming cancer care through scientific research, rapid development, and worldwide delivery of medicines. Its integrated approach aims to advance innovative therapies and expand access so more people with cancer can benefit from progress in treatment. The company’s research and development spans hematologic cancers and solid tumors, supported by a broad pipeline and programs in areas including protein degradation and antibody-drug conjugates.

Its clinical trials investigate potential treatments for high-burden cancers such as blood, lung, breast and gynecological, gastrointestinal, and rare cancers. BeOne also offers information about its medicines, clinical trials, investigator opportunities, and patient support, including expanded access programs. Beyond developing therapies, the company works with healthcare professionals, researchers, and partners, and provides medical information and safety reporting channels.

Its global operations, manufacturing capabilities, and commitment to responsible business practices support its goal of reaching patients worldwide. BeOne Medicines presents its work as a collective effort grounded in scientific excellence, speed, and a focus on the needs of people living with cancer